Unique ID issued by UMIN | UMIN000006691 |
---|---|
Receipt number | R000007908 |
Scientific Title | Effect of Atorvastatin and Amlodipine on pressure-diuresis curve |
Date of disclosure of the study information | 2011/11/08 |
Last modified on | 2014/05/19 08:54:56 |
Effect of Atorvastatin and Amlodipine on pressure-diuresis curve
Effect of Atorvastatin and Amlodipine on pressure-diuresis curve
Effect of Atorvastatin and Amlodipine on pressure-diuresis curve
Effect of Atorvastatin and Amlodipine on pressure-diuresis curve
Japan |
Patients with salt sensitive hypertension and LDL hyperlipemia
Medicine in general | Nephrology |
Others
NO
To examine whether the atorvastatin which carried out additional medication to the salt-sensitive-hypertension patient under amlodipine medication makes increase inclination of a pressure-diuresis curve.
Efficacy
pressure-diuresis curve
changes in value of the following data from baseline to the end of examination(Blood Pressure, Urine volume, urinary sodium concentration, urinary potasium concentration, urinary neutrophil gelatinase associated lipocalin2 (NGAL) consentration, urinary 8OH-dG concentration, total cholesterol, low density lipoprotein, triglyceride, high density lipoprotein, high sensitive C-reactive protein, serum Urea, serum creatinine, serum Na,K,Cl, plasma renin activity, plasma aldosterone concentration )
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Medicine | Food |
A salt restricted diet for three days is given to the patient under 5 mg of amlodipine administration. Then 10mg of atorvastatin added, a salt restricted diet for three days is given to the patient.
20 | years-old | <= |
Not applicable |
Male and Female
1) hypertension (systoric BP>140mmHg or diastoric BP>90mmHg) 2) hyper LDL-C (>120mg/dl) without statin treatment 3) serum Cr < 3.0mg/dl 4) over 20 years old 5) obtain written informed consent.
1) a patient who is treated with diuretics. 2) a patient who is treated with statins. 3) poor controlled hypertension (systoric BP>180mmHg or diastoric BP>110mmHg) 4) patient with heavy cardiovascular disease 5) hepatitis (ALT over three folds increase by normal limits) 6) pregnancy, child bearing potential pre- or nursing 7) uncontrolled arrhythmia 8) inadequate due to other reason by attending physician's judgments 9) history of hypersensitivity to atorvastatin
30
1st name | |
Middle name | |
Last name | Masato KASAHARA |
Kyoto University Hospital
Institute for Advancement of Clinical and Translational Science (iACT)
54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto
075-751-4724
kasa@kuhp.kyoto-u.ac.jp
1st name | |
Middle name | |
Last name | Masato KASAHARA |
Kyoto University Hospital
Institute for Advancement of Clinical and Translational Science (iACT)
54 Kawara-cho, Shogoin, Sakyo-ku, Kyoto
075-751-4724
kasa@kuhp.kyoto-u.ac.jp
Kyoto University
Pfizer Japan Inc.
Profit organization
NO
2011 | Year | 11 | Month | 08 | Day |
Unpublished
No longer recruiting
2011 | Year | 10 | Month | 28 | Day |
2011 | Year | 12 | Month | 01 | Day |
2013 | Year | 12 | Month | 10 | Day |
2014 | Year | 02 | Month | 20 | Day |
2014 | Year | 02 | Month | 25 | Day |
2011 | Year | 11 | Month | 08 | Day |
2014 | Year | 05 | Month | 19 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000007908
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |